biological activity | Kifunensine is a potent and selective inhibitor of class I α-mannosidases that can be isolated from Actinomycetes, the α-mannosidases I can be blocked from pruning mannose residues on glycoproteins. Kifunensine inhibits the endoplasmic reticulum-related protein degradation pathway. |
Cell Line:
| Hybridoma cells expressing a human IgG1 monoclonal Antibody [3] . |
Concentration:
| 2 μg/mL. |
Incubation Time:
| 4 days. |
Result:
| Significantly reduced the lentil lectin binding. Kifunensine is the most effective among the inhibitors tested in producing antibodies containing oligomannose residues without fucose. There was no significant difference in the serum levels of anti-TEM B mAb generated from cells treated with or without kifunensine in the 7-day period. |
Animal Model:
| BALB/c mice. |
Dosage:
| 5 mg/kg. |
Administration:
| IV via tail vein. |